NEIMETH.XNSA NEIMETH INTERNATIONAL PHARMACEUTICAL PLC
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is NEIMETH.XNSA undervalued?
Graham numberThe Graham number of NEIMETH INTERNATIONAL PHARMACEUTICAL PLC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC fundamental analysis
No fundamental analysis for NEIMETH INTERNATIONAL PHARMACEUTICAL PLC yet.
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of NEIMETH INTERNATIONAL PHARMACEUTICAL PLC are not available yet.
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC dividends
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC has not paid dividends in the last 1 fiscal years.
Who owns NEIMETH INTERNATIONAL PHARMACEUTICAL PLC
Ownership data of NEIMETH INTERNATIONAL PHARMACEUTICAL PLC is not available yet.
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC company profile
- Company name
- NEIMETH INTERNATIONAL PHARMACEUTICAL PLC
- Ticker
- NEIMETH.XNSA
- ISIN
- NGNEIMETH001
- Exchange
- Nigerian Stock Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -